Hims & Hers Ranks 106th in Trading Volume Amid 435% Surge Since 2024 31% Drop From February Peak as Insiders Sell Millions

On August 13, 2025, Hims & Hers Health (HIMS) closed with a 0.77% gain, trading at $46.91 with a trading volume of 0.92 billion, ranking 106th in market activity. The stock has seen a 435% surge since January 2024 but has declined 31% from its February 2025 peak. Recent insider transactions have drawn attention, including CEO Andrew Dudum’s $33.4 million sale of 660,000 shares via a trust for tax and philanthropic purposes. Dudum remains the largest shareholder, indirectly holding 8 million Class A shares and 8.4 million super-voting Class V shares, while emphasizing his commitment to the company’s long-term growth.

Additional insider sales included Soleil Boughton’s 2,572 shares and Patrick Harrison Carroll’s 60,000 shares, both reducing their stakes by over 1%. Analyst ratings have shifted, with Wall Street Zen lowering the stock to “hold” and Deutsche Bank maintaining a “hold” stance. Recent earnings reported $0.17 EPS and $544.83 million revenue, slightly below estimates, though year-over-year revenue growth reached 72.6%. The stock’s beta of 2.08 reflects heightened volatility, with a 50-day moving average at $53.39 and a 200-day average at $45.30.

Hims & Hers continues to navigate the weight-loss drug market despite losing a partnership with Novo Nordisk earlier this year. The company sells compounded generic versions of weight-loss medications, maintaining compliance with FDA regulations. Institutional investors own 63.52% of the stock, with hedge funds like Bessemer Group and Skandinaviska Enskilda Banken AB increasing holdings in Q2 2025. However, the stock’s elevated debt-to-equity ratio of 1.72 and mixed analyst sentiment highlight ongoing risks.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day from 2022 to 2025 delivered a 6.98% CAGR with a maximum drawdown of 15.59%. While demonstrating steady growth, the mid-2023 downturn underscores the importance of risk management in high-volume trading approaches.